SCHEMBL515409

SCHEMBL515409

C=CC(O)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12055831 1.00
SCHEMBL12054896 1.00
SCHEMBL174587 0.73
SCHEMBL30980 0.70
SCHEMBL2157236 0.70
SCHEMBL3519315 0.70
SCHEMBL7915199 0.68
SCHEMBL8161711 0.67
SCHEMBL30983 0.67
SCHEMBL45611 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005280-A2 PROCESS FOR THE PREPARATION OF LIPOPHILIC 4-HYDROXYALKYL BROMOBENZENE DERIVATIVES MIMOS BERHAD (MY) 2010-01-14 WO claimed
EP-4399197-A1 SELECTIVE SELF-ASSEMBLED MONOLAYERS VIA SPIN-COATING METHOD FOR USE IN DSA Merck Patent GmbH (DE) 2024-07-17 EP disclosed
EP-3856719-B1 COMPOUNDS AS NEURONAL HISTAMINE RECEPTOR-3 ANTAGONISTS AND USES THEREOF XWPHARMA LTD (KY) 2023-06-07 EP disclosed
WO-2023036720-A1 SELECTIVE SELF-ASSEMBLED MONOLAYERS VIA SPIN-COATING METHOD FOR USE IN DSA MERCK PATENT GMBH (DE) 2023-03-16 WO disclosed
US-20220380339-A1 COMPOUNDS AS NEURONAL HISTAMINE RECEPTOR-3 ANTAGONISTS AND USES THEREOF XWPharma Ltd. (KY) 2022-12-01 US disclosed
CN-114042070-A Compounds as neuronal histamine receptor-3 antagonists and uses thereof 凯瑞康宁生物工程(武汉)有限公司 2022-02-15 CN disclosed
CN-112004802-B Compounds as neuronal histamine receptor-3 antagonists and uses thereof 凯瑞康宁生物工程(武汉)有限公司 2021-12-28 CN disclosed
EP-3856719-A1 COMPOUNDS AS NEURONAL HISTAMINE RECEPTOR-3 ANTAGONISTS AND USES THEREOF XWPharma Ltd. (KY) 2021-08-04 EP disclosed
US-20210188808-A1 COMPOUNDS AS NEURONAL HISTAMINE RECEPTOR-3 ANTAGONISTS AND USES THEREOF XWPharma Ltd. (KY) 2021-06-24 US disclosed
EP-3475265-B1 COMPOUNDS FOR THE DETECTION OF SENESCENT CELLS UNIV MANCHESTER (GB) 2021-06-16 EP disclosed
CN-1610669-A Heteroaryl-substituted aminocyclohexane derivatives HOFFMANN LA ROCHE (CH) 2005-04-27 CN disclosed
US-20050065210-A1 Aminoalkylamide substituted cyclohexyl derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-03-24 US disclosed
CN-1471522-A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles - 2004-01-28 CN disclosed
CN-1468214-A Novel derivatives of aminocyclohexane - 2004-01-14 CN disclosed
EP-0396172-B1 Nonlinear optical compound, nonlinear optical medium, method of manufacturing a nonlinear optical medium and device for doubling the frequency of a light wave PHILIPS NV (NL) 1994-08-24 EP disclosed
US-5006729-A Optical compound in polymer matrix, each containing sulfone group U.S. PHILIPS CORPORATION (US) 1991-04-09 US disclosed
EP-0396172-A1 Nonlinear optical compound, nonlinear optical medium, method of manufacturing a nonlinear optical medium and device for doubling the frequency of a light wave Koninklijke Philips Electronics N.V. (NL) 1990-11-07 EP disclosed
US-4250097-A (7-METHYL(2-HYDROXYETHYL)AMINO)SULFONYLXANTHONE-2-CARBOXYLIC ACID; ENZYME INHIBITORS SYNTEX (U.S.A.) INC. (US) 1981-02-10 US disclosed
US-4232040-A XANTHONE CARBOXYLIC ACIDS SYNTEX (U.S.A.) INC. (US) 1980-11-04 US disclosed
US-4217361-A Disubstituted xanthone-2-carboxylic acid antiallergy agents SYNTEX (U.S.A.) INC. (US) 1980-08-12 US disclosed